Structure Therapeutics, Inc. (GPCR)
41.53
+0.28
(+0.68%)
USD |
NASDAQ |
Jun 10, 16:00
41.49
-0.04
(-0.10%)
After-Hours: 17:06
Structure Therapeutics 1 Year Total Returns (Daily) : 101.1% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 101.1% |
| June 08, 2026 | 78.75% |
| June 05, 2026 | 75.03% |
| June 04, 2026 | 77.55% |
| June 03, 2026 | 70.69% |
| June 02, 2026 | 70.67% |
| June 01, 2026 | 77.16% |
| May 29, 2026 | 75.47% |
| May 28, 2026 | 80.95% |
| May 27, 2026 | 65.72% |
| May 26, 2026 | 61.22% |
| May 22, 2026 | 58.99% |
| May 21, 2026 | 60.62% |
| May 20, 2026 | 49.45% |
| May 19, 2026 | 43.52% |
| May 18, 2026 | 43.46% |
| May 15, 2026 | 58.37% |
| May 14, 2026 | 67.29% |
| May 13, 2026 | 59.40% |
| May 12, 2026 | 53.70% |
| May 11, 2026 | 49.86% |
| May 08, 2026 | 45.79% |
| May 07, 2026 | 47.18% |
| May 06, 2026 | 61.23% |
| May 05, 2026 | 49.21% |
| Date | Value |
|---|---|
| May 04, 2026 | 58.88% |
| May 01, 2026 | 54.45% |
| April 30, 2026 | 53.52% |
| April 29, 2026 | 59.65% |
| April 28, 2026 | 84.42% |
| April 27, 2026 | 90.94% |
| April 24, 2026 | 92.35% |
| April 23, 2026 | 101.6% |
| April 22, 2026 | 101.8% |
| April 21, 2026 | 102.7% |
| April 20, 2026 | 121.6% |
| April 17, 2026 | 133.2% |
| April 16, 2026 | 188.7% |
| April 15, 2026 | 187.0% |
| April 14, 2026 | 180.8% |
| April 13, 2026 | 241.2% |
| April 10, 2026 | 262.2% |
| April 09, 2026 | 261.1% |
| April 08, 2026 | 275.3% |
| April 07, 2026 | 282.1% |
| April 06, 2026 | 242.4% |
| April 02, 2026 | 215.5% |
| April 01, 2026 | 217.7% |
| March 31, 2026 | 178.5% |
| March 30, 2026 | 122.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Eli Lilly & Co. | 48.98% |
| Novo Nordisk A/S | -41.53% |
| Viking Therapeutics, Inc. | 6.02% |
| Pfizer Inc. | 14.75% |
| Tarsus Pharmaceuticals, Inc. | 42.77% |